Robert Iannone

EVP, Global Head of R&D & CMO, Jazz Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$20.4M

Companies

Latest trade

Aug 27, 2026

Companies

Jazz PharmaceuticalsEVP, Global Head of R&D & CMO −$20.4M

Trades

JAZZ Sold 76,921 shares at $249.70 · planned $19.2M Aug 27

JAZZ Sold 7,159 shares at $168.26 · planned $1.2M Nov 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.